Affiliation:
1. Biodesign Center Key Laboratory of Engineering Biology for Low‐Carbon Manufacturing Tianjin Institute of Industrial Biotechnology Chinese Academy of Sciences Tianjin China
2. National Center of Technology Innovation for Synthetic Biology Tianjin China
3. Haihe Laboratory of Synthetic Biology Tianjin China
Abstract
AbstractRecent advances in biofoundries have enabled the construction of a large quantity of strains in parallel, accelerating the design‐build‐test‐learn (DBTL) cycles for strain development. However, the construction of a large number of strains by iterative gene manipulation is still time‐consuming and costly, posing a challenge for the development of commercial strains. Common gene manipulations among different objective strains open up the possibility of reducing cost and time for strain construction in biofoundries by optimizing genetic manipulation schedules. A method is introduced consisting of two complementary algorithms for designing optimal parent‐children manipulation schedules for strain construction: greedy search of common ancestor strains (GSCAS) and minimizing total manipulations (MTM). By reusing common ancestor strains, the number of strains to be constructed can be effectively reduced, resulting in a tree‐like structure of descendants instead of linear lineages for each strain. The GSCAS algorithm can quickly find common ancestor strains and clusters them together based on their genetic makeup, and the MTM algorithm subsequently minimize the genetic manipulations required, resulting in a further reduction in the total number of genetic manipulations. The effectiveness of our method is demonstrated through a case study of 94 target strains, where GSCAS reduces an average of 36% of the total gene manipulations, and MTM reduces an additional 10%. The performance of both algorithms is robust among case studies with different average occurrences of gene manipulations across objective strains. Our method potentially improves cost efficiency and accelerate the development of commercial strains significantly. The implementation of the methods can be freely accessed via https://gscas‐mtm.biodesign.ac.cn/
Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
China Postdoctoral Science Foundation
Subject
Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine